Erlotinib administration for advanced non-small cell lung cancer during the first 2 months of unrecognized pregnancy (Q46863327)

From Wikidata
Jump to navigation Jump to search
scientific article published on 11 December 2007
edit
Language Label Description Also known as
English
Erlotinib administration for advanced non-small cell lung cancer during the first 2 months of unrecognized pregnancy
scientific article published on 11 December 2007

    Statements

    Erlotinib administration for advanced non-small cell lung cancer during the first 2 months of unrecognized pregnancy (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit